“Dopamine D3 receptor-directed medication development for the treatment of substance use disorders: Rationale, progress, and challenges”
Featured Speaker
Amy Hauck Newman, PhD
National Institute of Health
Scientific Director, NIDA IRP
Chief, Molecular Targets and Medications Discovery Branch
Chief, Medicinal Chemistry Section
Director, Medication Development Program
This seminar will be held IN-PERSON at the UHSP Academic and Research Building, room 222
Questions? Please contact Emma Witzke.